Present robust, evidence-based updates on NGPs’ role in tobacco harm reduction, including key studies, scientific consensus, risk communication strategies, and implications for future EU policy frameworks.
Host:
Philipp Markl
Panellists:
Moderator, Berater und Dozent
Moderator, consultant, and lecturer
Dr Sydney Hiller is Director US Regulatory Operations at Inter Scientific. She has extensive experience integrating scientific rigour with regulatory strategy to support product development, market entry, and compliance in highly regulated sectors, including tobacco harm reduction and cannabis. Sydney earned her Ph.D. in Chemistry from the University of Southern California and her B.A. from New York University, conducting research under Raphael Mechoulam, the pioneering figure in cannabis science. Actively engaged in professional societies, she is committed to advancing women in STEM, serving as a mentor for Women in Science & Engineering (WiSE) and Women in Chemistry (WiC), and is a member of the Organisation of Women in Nicotine and Tobacco (OWNiT).
Dr Sydney Hiller is Director US Regulatory Operations at Inter Scientific. She has extensive experience integrating scientific rigour with regulatory strategy to support product development, market entry, and compliance in highly regulated sectors, including tobacco harm reduction and cannabis. Sydney earned her Ph.D. in Chemistry from the University of Southern California and her B.A. from New York University, conducting research under Raphael Mechoulam, the pioneering figure in cannabis science. Actively engaged in professional societies, she is committed to advancing women in STEM, serving as a mentor for Women in Science & Engineering (WiSE) and Women in Chemistry (WiC), and is a member of the Organisation of Women in Nicotine and Tobacco (OWNiT).
Sairah is a chartered health psychologist and award-winning stop-smoking clinician with 20 years of experience in smoking cessation and tobacco harm reduction. She is the Managing Director of Salim-Sartoni Associates (SSA).
She supports the vaping industry with scientific, clinical and regulatory expertise and provides evidence-based training for healthcare professionals to reduce misinformation and build confidence in vaping as a stop-smoking tool.
Sairah is also involved in the national Swap to Stop programme, helping vulnerable smokers transition away from tobacco. She is a passionate advocate and public speaker committed to leaving no smoker behind.
Sairah is a chartered health psychologist and award-winning stop-smoking clinician with 20 years of experience in smoking cessation and tobacco harm reduction. She is the Managing Director of Salim-Sartoni Associates (SSA).
She supports the vaping industry with scientific, clinical and regulatory expertise and provides evidence-based training for healthcare professionals to reduce misinformation and build confidence in vaping as a stop-smoking tool.
Sairah is also involved in the national Swap to Stop programme, helping vulnerable smokers transition away from tobacco. She is a passionate advocate and public speaker committed to leaving no smoker behind.